Prosecution Insights
Last updated: April 19, 2026

Prelude Therapeutics Incorporated

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18482098 CDK Inhibitors And Their Use As Pharmaceuticals ROBINSON, MIKHAIL O'DONNEL 1627 Non-Final OA Oct 06, 2023
18336117 KAT6 TARGETING COMPOUNDS JOHNSON, CHRISTOPHER LINDSAY 1691 Non-Final OA Jun 16, 2023
18317352 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE KIFLE, BRUCK 1624 Final Rejection May 15, 2023
18185193 CDK Inhibitors And Their Use As Pharmaceuticals VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Non-Final OA Mar 16, 2023

Managing Prelude Therapeutics Incorporated's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month